Consensus Enlivex Börse Stuttgart

Stocks

1BT

IL0011319527

Real-time Estimate Tradegate 12:02:01 21/08/2026 am IST			5-day change	1st Jan Change
1.295 ^EUR	-10.69%		-7.64%	-84.15%

28/07	Enlivex Ltd. announced that it expects to receive $400 million in funding	CI
13/07	Enlivex Receives FDA Regenerative Medicine Advanced Therapy Designation for Allocetra in Age-Related Knee Osteoarthritis	CI

Evolution of the Average Target: Enlivex

Evolution of the Target Price: Enlivex

Changes in Analyst Recommendations: Enlivex

390ff2e685d3f4618bc4f07d7c37b3aa.H33AeCc-h51Tv6ydGUjV_mdCjZwcoqQwirobmspfrFM.aD_4IW90svE-6vrXKgKai1c7y-1IzftEsuJD4oEnxCInEpIOfXvxzCTQ2w~e643e46c0f8972e1370b17af91e99a81

Analysts' recommendations: Enlivex

11/24/11	HC Wainwright Adjusts Price Target on Enlivex Therapeutics to $6 From $7, Maintains Buy Rating	MT
12/24/12	HC Wainwright Adjusts Enlivex Therapeutics Price Target to $7 From $12, Maintains Buy Rating	MT
25/23/25	HC Wainwright Cuts Enlivex Therapeutics Price Target to $12 From $15, Maintains Buy Rating	MT
02/22/02	HC Wainwright Adjusts Enlivex Therapeutics' Price Target to $15 from $33, Keeps Buy Rating	MT

More recommendations

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.730USD

Average target price

80.00USD

Spread / Average Target

+4,524.28%

High Price Target

80.00USD

Spread / Highest target

+4,524.28%

Low Price Target

80.00USD

Spread / Lowest Target

+4,524.28%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.730USD

Average target price

80.00USD

Spread / Average Target

+4,524.28%

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

The best tools reserved for subscribers to boost the performance of your investments!